The Travelers Companies, Inc. (LON:0R03)

CTI BioPharma Revenue

The Travelers Companies had revenue of $12.12B USD in the quarter ending June 30, 2025, with 7.38% growth. This brings the company's revenue in the last twelve months to $47.84B, up 8.54% year-over-year. In the year 2024, The Travelers Companies had annual revenue of $46.42B with 12.23% growth.

• Revenue (ttm): $47.84B
• Revenue Growth: +8.54%
• P/S Ratio: 1.26
• Revenue / Employee: $1.41M
• Employees: 34,000
• Market Cap: 43.90B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	46.42B	5.06B	12.23%
Dec 31, 2023	41.36B	4.48B	12.15%
Dec 31, 2022	36.88B	2.07B	5.94%
Dec 31, 2021	34.82B	2.84B	8.86%
Dec 31, 2020	31.98B	400.00M	1.27%